Abstract

BackgroundNo satisfactory biomarkers are currently available to screen for nasopharyngeal carcinoma (NPC). We have developed and evaluated surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) for detection and analysis of multiple proteins for distinguishing individuals with NPC from control individuals.MethodsA preliminary learning set and a classification tree of spectra derived from 24 patients with NPC and a group of 24 noncancer controls were used to develop a proteomic model that discriminated cancer from noncancer effectively. Then, the validity of the classification tree was challenged with a blind test set, which included another 20 patients with NPC and 12 noncancer controls.ResultsA panel of 3 biomarkers ranging m/z 3–20 k was selected to establish Decision Tree model by BPS with sensitivity of 91.66% and specificity of 95.83%. The ability to detect NPC patients was evaluated, a sensitivity of 95.0% and specificity of 83.33% were validated in blind testing set.ConclusionThis high-flux proteomic classification system will provide a highly accurate and innovative approach for the detection/diagnosis of NPC.

Highlights

  • No satisfactory biomarkers are currently available to screen for nasopharyngeal carcinoma (NPC)

  • NPC is highly sensitive to radiotherapy (RT) and chemotherapy (CT), but the outcome is related to the extent of the disease

  • Serum SELDI profiles of NPC versus nocancer normal controls After noise filtering and peak cluster identification, 94 mass peaks were detected in the training set

Read more

Summary

Introduction

No satisfactory biomarkers are currently available to screen for nasopharyngeal carcinoma (NPC). We have developed and evaluated surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) for detection and analysis of multiple proteins for distinguishing individuals with NPC from control individuals. Nasopharyngeal carcinoma (NPC) is a disease that has remarkable racial and geographic distribution [1]. It is rare in Europe and North America. It has a high incidence in several southern areas in China, especially in the provinces of Guangdong, Guangxi, Hunan and Hong Kong Special Administrative Region et al [2]. NPC is highly sensitive to radiotherapy (RT) and chemotherapy (CT), but the outcome is related to the extent of the disease. Early detection and (page number not for citation purposes)

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.